secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMAC Holdings, Inc. (BACK)
CIK:        0001729944
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0001641172-25-022584
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IMAC Holdings announces VUMC collaboration for breast cancer biomarker RPPA profiling; issues $84K discounted note
--------------------------------------------------------------------------------

- One-year research collaboration with Vanderbilt University Medical Center; VUMC supplies 80 FFPE breast-cancer samples, Ignite performs RPPA analysis.
- Ignite receives exclusive option to negotiate a worldwide license to jointly developed IP; each party bears own costs.
- Issued $84,000 promissory note for $60,000 purchase price; unsecured, matures December 24, 2025.
- Initial data packages expected within 2 months of sample receipt; collaboration aims to identify immunotherapy response biomarkers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729944/000164117225022584/0001641172-25-022584-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729944/000164117225022584/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-022584

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer